Group B streptococcal disease in UK and Irish infants younger than 90 days. - Wikidata - wikimedia - TriplyDB

Group B streptococcal disease in UK and Irish infants younger than 90 days.

Group B streptococcal disease in UK and Irish infants younger than 90 days.

http://www.wikidata.org/entity/Q34293655

about

Antenatal screening for Group B Streptococcus: a diagnostic cohort study.Common respiratory conditions of the newborn Antibiotic use and misuse during pregnancy and delivery: benefits and risks Prevention of neonatal group B streptococcus disease in the 21st century Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands.Group B streptococcal beta-hemolysin/cytolysin directly impairs cardiomyocyte viability and function Neonatal group B streptococcal disease: incidence, presentation, and mortality.Neonatal infections: group B streptococcus.Induction and termination of inflammatory signaling in group B streptococcal sepsis.Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment Antenatal immunization Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro.Interaction of neonatal phagocytes with group B streptococcus: recognition and response.International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci)Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Invasive group B streptococcal infection in infants in Shenzhen, China Group B streptococcal infection and activation of human astrocytes.Carriage of group B streptococcus in pregnant women from Oxford, UK.Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study.Significance, management and prevention of Streptococcus agalactiae infection during the perinatal period.Rapid diagnosis of intrapartum group B streptococcal carriage by fluorescent in situ hybridisation.Beyond counting cases: public health impacts of national Paediatric Surveillance Units.Vaccination against group B streptococcus.Severe sepsis in women with group B Streptococcus in pregnancy: an exploratory UK national case-control study.Toll-like receptor-dependent discrimination of streptococci.Group B Streptococcus: global incidence and vaccine development.First molecular characterization of group B streptococci with reduced penicillin susceptibility.Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention.Maternal and neonatal risk factors for early-onset group B streptococcal disease: a case control study.Invasive group B streptococcal infection in infants, Malawi Prevention of neonatal group B streptococcal disease.Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility.Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune Responses [Clinical relevance of antibiotic resistance in obstetrics and gynecology].An update on vaccination against group B streptococcus.

P2860

Q24815555-F2FD8747-D9B6-4C15-A2C9-F7B4CBE4CF16 Q26750445-02E1D726-0B8F-41DB-BF65-4B19F07563C3 Q27003944-79BA3D97-A3B3-43B0-9261-63202779A5C9 Q29399413-678EDACE-E128-4534-B28F-3295F5F93FF3 Q30431534-622AE3D7-E78E-492D-8233-B422B9081609 Q31125479-9B6D6F10-8BBC-41C4-8245-5D59FF13D015 Q33344477-B2D70A7E-4619-4017-BA27-15DE5E80C09F Q33378153-8FFB10A4-3B0F-4798-AF1E-C0C67B60F364 Q33446762-3AF9221C-E9EA-4607-AA32-9B797FB6F3DA Q33608933-8AD54856-B34C-49C0-8CDE-1CCF3ED742D5 Q33682806-A92B6636-5EAA-42F2-B4E3-020ED13C74F2 Q33719415-EED3615B-A235-4DEC-8886-5D7238C8F864 Q34082651-2A60FF2D-FE11-4DFE-8917-178F2F3F41DD Q34291016-ED6DFDB8-C789-4D43-B4B5-C8C59701614C Q34382537-8AF4CA59-460E-46FB-ADF5-13B078B839F6 Q34681095-BD403CE1-E704-4864-AD2F-ABCCB9D1F3C3 Q35066957-923F5AFA-87F1-45F5-8936-61D6EAE45F9D Q35122775-9F56F234-24EB-4679-9817-4CB9C1C76C58 Q35481809-DE88B3CB-C389-496C-9424-9154C451E1EE Q35648179-248E4A33-41A2-447F-AE4F-CFEF1A3A6199 Q35769938-6CFDFEA9-AE9A-4428-94BF-F08EF7427EE8 Q35795653-3E6A84C5-5E72-4ADA-9EE6-471C194DEC9A Q35917434-4BECBAD2-1D82-49EE-A9FC-FBCC6A2D8833 Q36017202-6E35EB36-B5FE-4724-8329-932D0847A9B8 Q36121700-05E38F0D-748B-4B91-ADE6-9626801C11FC Q36124960-2B0F5DCC-B0D0-48C6-844E-01E38C3BD666 Q36163560-E0F80819-F00B-4F62-A111-3C1BE2D46FEF Q36632391-85B263BE-6F02-40C4-BDBE-D097C9A3832B Q36646803-CD23E60B-84C0-4B30-ACCB-316F4E3BD801 Q36803947-23FA343C-C4C2-4A1F-9E47-D82A54F4823E Q37174864-73065B03-C21D-44FB-9FE7-9DEDE07120C9 Q37272583-38F1664F-7EB4-4C28-9B39-52A107050117 Q37302693-C00B341C-3C85-4CE6-8CAB-DF9EEA8835CC Q37359329-81717680-A5B9-459D-972D-C52F2C1BC2F5 Q37451778-1AFBA98D-77E0-4DAA-BB8F-C2A8A29F7791 Q37614189-CDB13071-E479-48E2-8E91-BDAE03277209 Q37643673-AC792A6E-ADEE-487A-8A67-0BB2C42D53E6 Q37683149-FF837E5C-7E48-43B4-9959-38ECFA85C5B3 Q37865755-D4D24E1A-6A18-4865-96CA-EA4760613A3D Q37878487-0E050D21-0726-4811-8D74-D7A8383392E3

P2860

Group B streptococcal disease in UK and Irish infants younger than 90 days.

http://www.wikidata.org/entity/Q34293655

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@ast

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@en

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@nl

type

label

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@ast

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@en

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@nl

prefLabel

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@ast

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@en

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@nl

P1433

Q34293655-6A09A7B0-009D-47E8-9360-1E0798A11C65

P1476

Q34293655-20D56D79-2828-4123-94FE-ED4F0BE636B3

P2093

Q34293655-1652B150-12B2-4DC9-A145-943FA9B4232D

Q34293655-4B7DAF7F-290D-49BF-8DA8-CBCD8F735073

Q34293655-4EC8B8AE-3EAF-4486-AC5D-A1AD13156ACD

Q34293655-603900D0-0A69-450B-AD78-2F96EBBCFE72

Q34293655-688277F5-FA9A-41B7-B6EB-3A882B4ED8B8

Q34293655-7573C415-1E59-44D9-B987-CC200E6E43CA

Q34293655-A63D7803-C1E7-48AA-9D2E-60D2D5E57320

Q34293655-AA54C13D-9156-479F-BC92-B97FC5092BAC

Q34293655-AE2027BF-A00C-4EE0-98B0-3EE956B0E21D

Q34293655-F06A3D53-5D47-47FD-AAC1-941A6E4DF5C0

P304

Q34293655-D2CE6AF3-985F-47C9-9AF4-98D129FBA8FE

P31

Q34293655-8C461EFF-91FA-455D-8F03-0B694C321708

P356

Q34293655-05EE0C97-2283-4881-9D70-143F926C97FB

P407

Q34293655-5482EDE9-E1AA-4C08-9B6B-093628DC0AEC

P433

Q34293655-0CD2045C-4145-4BB1-AE7A-EA3CE124263A

P478

Q34293655-DCD6E946-D4DE-4548-83B6-D3B6A5565EC9

P50

Q34293655-5ADFBB08-5638-4FEE-87A0-1EE282D7B54E

Q34293655-E4F6E7C9-F506-44BE-A1BF-9B0BBCCDE5F1

P577

Q34293655-FA4CD441-3C42-4762-882F-E8AE936F1A29

P698

Q34293655-CA00CF0E-589F-4350-A292-E7FD22349114

P356

S0140-6736(03)15389-5

P1433

P1476

Group B streptococcal disease in UK and Irish infants younger than 90 days.

@en

P2093

A Christine McCartney

http://www.w3.org/2001/XMLSchema#string

Abbie M Weisner

http://www.w3.org/2001/XMLSchema#string

Androulla Efstratiou

http://www.w3.org/2001/XMLSchema#string

Angus Nicoll

http://www.w3.org/2001/XMLSchema#string

Gail Balfour

http://www.w3.org/2001/XMLSchema#string

Helen Tighe

http://www.w3.org/2001/XMLSchema#string

Liam A F O'Connell

http://www.w3.org/2001/XMLSchema#string

Mary Cafferkey

http://www.w3.org/2001/XMLSchema#string

Neville Q Verlander

http://www.w3.org/2001/XMLSchema#string

PHLS Group B Streptococcus Working Group

http://www.w3.org/2001/XMLSchema#string

P304

292-294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(03)15389-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

9405

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P50

Theresa L Lamagni

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14751704

http://www.w3.org/2001/XMLSchema#string